Invitation to Brighter's Q1 2022 Conference Call

Brighter AB (Publ) ("Brighter") announced today that it will publish its report for Q1 2022 on Wednesday , May 4, 2022.

Members of Brighter's team will hold a conference call (in Swedish) for shareholders, analysts, and the media on Wednesday May 4, 2022 at 15.00 CET to present the results. The presentation is followed by a question and answer session. Brighter encourages those who intend to participate in the conference call to send questions to ir@brighter.se in advance.

We look forward to your participation.

Telephone conference in Swedish
To connect, register your details via the registration link below. Once you have registered, you will receive a separate email with your dialing numbers and PIN codes.

Date / time: May 4, 2022, at 15:00 CET
(Amsterdam, Berlin, Bern, Rome, Stockholm, Vienna)

Registration: Click here for registration

For further information, please contact:
Investor Relations
ir@brighter.se

Certified Adviser
Brighter’s Certified Adviser är Mangold Fondkommission AB,
+46 8 5277 5020, ca@mangold.se, www.mangold.se.

About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is a key to providing smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones, and their care providers – aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter's quality management system is ISO-13485 certified. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.

For more information, please visit our website at https://brighter.se/.